The Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has submitted a disclosure under the Irish Takeover Panel's Rule 8.3. This concerns its position in Mural Oncology plc, dated June 25, 2025. The disclosure highlights Vanguard's interest exceeding 1% in Mural Oncology's securities.

Vanguard holds 772,963 $0.01 ordinary shares, representing a 4.48% ownership stake. No short positions or other derivatives are noted. The document further reveals a recent transaction where Vanguard sold 32 ordinary shares at $2.46 each.

No new agreements or inducements related to these securities are disclosed. Additionally, there are no formal arrangements impacting voting rights or further acquisitions, indicating a straightforward holding strategy by Vanguard.